Reuters logo
BRIEF-Regulus Therapeutics Q3 loss per share $0.18
November 8, 2017 / 12:27 AM / 11 days ago

BRIEF-Regulus Therapeutics Q3 loss per share $0.18

Nov 7 (Reuters) - Regulus Therapeutics Inc:

* Regulus reports third quarter 2017 financial results and recent events

* Q3 revenue was less than $100,000

* Q3 loss per share $0.18

* Q3 revenue view $864,000 -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below